Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.92
-0.65 (-8.59%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Aardvark Therapeutics Employees
Aardvark Therapeutics had 22 employees as of December 31, 2024.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$935,818
Market Cap
151.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
AARD News
- 18 days ago - Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week - Seeking Alpha
- 2 months ago - Aardvark Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha
- 2 months ago - Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments - Seeking Alpha
- 3 months ago - Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut - Fierce Biotech
- 3 months ago - Aardvark Therapeutics IPO Registration Document (S-1) - SEC